Limited Dose-Dependent Effects of Vedolizumab on Various Leukocyte Subsets-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Limited Dose-Dependent Effects of Vedolizumab on Various Leukocyte Subsets

Published:2022-05-13 Issue:6 Volume:13 Page:e00494
ISSN:2155-384X
Container-title:Clinical and Translational Gastroenterology
language:en
Short-container-title:Clinical and Translational Gastroenterology

Author:

Becker Emily,Schweda Anna,Ullrich Karen A. -M.,Voskens Caroline,Atreya Raja,Müller Tanja M.,Atreya Imke,Neurath Markus F.,Zundler Sebastian

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology

Reference41 articles.

1. Immune cell trafficking and retention in inflammatory bowel disease: Mechanistic insights and therapeutic advances;Zundler;Gut,2019

2. Targeting immune cell trafficking – insights from research models and implications for future IBD therapy;Wiendl;Front Immunol,2021

3. Getting to the site of inflammation: The leukocyte adhesion cascade updated;Ley;Nat Rev Immunol,2007

4. Vedolizumab as induction and maintenance therapy for ulcerative colitis;Feagan;N Engl J Med,2013

5. Vedolizumab as induction and maintenance therapy for Crohn's disease;Sandborn;N Engl J Med,2013

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fluorescently labelled vedolizumab to visualise drug distribution and mucosal target cells in inflammatory bowel disease;Gut;2024-04-05

2. Single-cell and spatial multi-omics highlight effects of anti-integrin therapy across cellular compartments in ulcerative colitis;Nature Communications;2024-02-19

3. Meta-analysis of etrolizumab versus placebo in ulcerative colitis: safety and efficacy outcomes;Therapeutic Advances in Gastroenterology;2024-01

4. Using fluorescently labeled vedolizumab to visualize local drug distribution during colonoscopy and identify mucosal target cells in patients with inflammatory bowel disease;2023-10-26

5. Anti‐β7 integrin treatment impedes the recruitment on non‐classical monocytes to the gut and delays macrophage‐mediated intestinal wound healing;Clinical and Translational Medicine;2023-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3